Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, May 8 2025

Full Issue

Moderna's Combo Covid/Flu Shot Offers More Protection Than Separate Jabs

The trial, which involved more than 8,000 adults 50 and older, found that antibody levels generated by the new vaccine were about 20% to 40% higher than getting the shots apart, with the exception of one influenza strain. Plus: An FDA panel will meet May 22 to discuss covid shot recommendations.

Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the results of a phase 3 clinical trial published Wednesday in the Journal of the American Medical Association. The vaccine uses the same messenger RNA technology as Moderna’s approved Covid vaccine. (There are no approved mRNA-based flu shots.) (Lovelace Jr., 5/7)

In related news about the covid vaccine —

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 vaccine recommendations for the upcoming immunization campaign. The meeting comes after the appointment of Martin Makary as FDA commissioner. Makary had earlier raised concerns about a number of public health efforts during the COVID-19 pandemic, touted the protection received from natural immunity and opposed vaccine mandates for the general public. (5/7)

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want to ban them and the government is cutting funding. (Zernike, 5/8)

In other covid developments —

Patients with long COVID may exhibit persistent inflammation in the heart and lungs for up to 1 year following acute COVID-19 infection, even when standard medical tests return normal results, according to a new study in the Journal of Nuclear Medicine. The study authors, from the Icahn School of Medicine at Mount Sinai, suggest the inflammation may increase the risk for future cardiac and pulmonary conditions. (Soucheray, 5/7)

Poor self-reported general health (SRGH) is substantially more common among US adults with long COVID than among those without persistent symptoms (26% vs 16%), data from Pennsylvania State University investigators suggest. Long-COVID patients also had more unfavorable mental and physical health and lower daily efficiency when completing daily activities for more than 13 days a month, according to the findings, published this week in PLOS One. (Van Beusekom, 5/7)

In the early 2000s, a coronavirus infecting bats jumped into raccoon dogs and other wild mammals in southwestern China. Some of those animals were sold in markets, where the coronavirus jumped again, into humans. The result was the SARS pandemic, which spread to 33 countries and claimed 774 lives. A few months into it, scientists discovered the coronavirus in mammals known as palm civets sold in a market at the center of the outbreak. In a study published on Wednesday, a team of researchers compared the evolutionary story of SARS with that of Covid 17 years later. (Zimmer, 5/7)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ